The Alcohol Clinical Trials Initiative (ACTIVE): Purpose and Goals for Assessing Important and Salient Issues for Medications Development in Alcohol Use Disorders

Source: Neuropsychopharmacology

The Alcohol Clinical Trials Initiative (ACTIVE): Purpose and Goals for Assessing Important and Salient Issues for Medications Development in Alcohol Use Disorders

Neuropsychopharmacology 37,
402 (January 2012). doi:10.1038/npp.2011.182

Authors: Raymond F Anton, Raye Z Litten, Daniel E Falk, Joseph M Palumbo, Raymond T Bartus, Rebecca L Robinson, Henry R Kranzler, Thomas R Kosten, Roger E Meyer, Charles P O'Brien, Karl Mann
& Didier Meulien

Keywords: addiction and substance abuse; clinical pharmacology/clinical trials; alcohol and alcoholism; drug discovery/development; alcohol

View the original article

Login or register to help identify topics from this page.

This page may contain content contributed by CPNP members or aggregated from other online sources. This content is provided as an unmoderated service to members for civil discussion and collaboration. Any opinions, conclusions, or recommendations are those of the author. If you come across any abuse or violation of the terms of use, please report the abuse.